Department of Medicine, Division of Hospital Medicine, University of California San Francisco, San Francisco, California, USA.
Sarah Cannon, Genospace, HCA Healthcare Research Institute, Nashville, Tennessee, USA.
J Hosp Med. 2023 May;18(5):413-423. doi: 10.1002/jhm.13106. Epub 2023 Apr 14.
Identifying COVID-19 patients at the highest risk of poor outcomes is critical in emergency department (ED) presentation. Sepsis risk stratification scores can be calculated quickly for COVID-19 patients but have not been evaluated in a large cohort.
To determine whether well-known risk scores can predict poor outcomes among hospitalized COVID-19 patients.
DESIGNS, SETTINGS, AND PARTICIPANTS: A retrospective cohort study of adults presenting with COVID-19 to 156 Hospital Corporation of America (HCA) Healthcare EDs, March 2, 2020, to February 11, 2021.
Quick Sequential Organ Failure Assessment (qSOFA), Shock Index, National Early Warning System-2 (NEWS2), and quick COVID-19 Severity Index (qCSI) at presentation.
The primary outcome was in-hospital mortality. Secondary outcomes included intensive care unit (ICU) admission, mechanical ventilation, and vasopressors receipt. Patients scored positive with qSOFA ≥ 2, Shock Index > 0.7, NEWS2 ≥ 5, and qCSI ≥ 4. Test characteristics and area under the receiver operating characteristics curves (AUROCs) were calculated.
We identified 90,376 patients with community-acquired COVID-19 (mean age 64.3 years, 46.8% female). 17.2% of patients died in-hospital, 28.6% went to the ICU, 13.7% received mechanical ventilation, and 13.6% received vasopressors. There were 3.8% qSOFA-positive, 45.1% Shock Index-positive, 49.8% NEWS2-positive, and 37.6% qCSI-positive at ED-triage. NEWS2 exhibited the highest AUROC for in-hospital mortality (0.593, confidence interval [CI]: 0.588-0.597), ICU admission (0.602, CI: 0.599-0.606), mechanical ventilation (0.614, CI: 0.610-0.619), and vasopressor receipt (0.600, CI: 0.595-0.604).
Sepsis severity scores at presentation have low discriminative power to predict outcomes in COVID-19 patients and are not reliable for clinical use. Severity scores should be developed using features that accurately predict poor outcomes among COVID-19 patients to develop more effective risk-based triage.
在急诊科(ED)就诊时,识别 COVID-19 患者中预后不良风险最高的患者至关重要。Sepsis 风险分层评分可快速计算 COVID-19 患者,但尚未在大样本中进行评估。
确定已知风险评分是否可预测住院 COVID-19 患者的不良结局。
设计、地点和参与者:2020 年 3 月 2 日至 2021 年 2 月 11 日,对 156 家 Hospital Corporation of America (HCA) Healthcare ED 就诊的 COVID-19 成年患者进行回顾性队列研究。
就诊时的快速序贯器官衰竭评估(qSOFA)、休克指数、国家早期预警系统-2(NEWS2)和快速 COVID-19 严重程度指数(qCSI)。
主要结局为院内死亡率。次要结局包括 ICU 入院、机械通气和血管加压素的使用。qSOFA≥2、休克指数>0.7、NEWS2≥5 和 qCSI≥4 的患者评分阳性。计算了测试特征和接受者操作特征曲线(AUROCs)下的面积。
我们确定了 90376 例社区获得性 COVID-19 患者(平均年龄 64.3 岁,46.8%为女性)。17.2%的患者院内死亡,28.6%进入 ICU,13.7%接受机械通气,13.6%接受血管加压素。就诊时,3.8%的患者 qSOFA 阳性,45.1%的患者休克指数阳性,49.8%的患者 NEWS2 阳性,37.6%的患者 qCSI 阳性。NEWS2 对院内死亡率(0.593,置信区间 [CI]:0.588-0.597)、ICU 入院(0.602,CI:0.599-0.606)、机械通气(0.614,CI:0.610-0.619)和血管加压素使用(0.600,CI:0.595-0.604)的预测具有最高的 AUROC。
就诊时的 Sepsis 严重程度评分对预测 COVID-19 患者的结局具有较低的区分能力,不能用于临床。严重程度评分应使用可准确预测 COVID-19 患者不良结局的特征进行开发,以制定更有效的基于风险的分诊。